Evidence map›Paper›PMID 26610845›Full record

ArticleMedical science monitor : international medical journal of experimental and clinical research2015

Association of Retinoid X Receptor Alpha Gene Polymorphism with Clinical Course of Chronic Glomerulonephritis.

Alicja E Grzegorzewska, Grzegorz Ostromecki, Paulina Zielińska, Adrianna Mostowska, Zofia Niemir, Magdalena Polcyn-Adamczak, Magdalena Pawlik, Anna Sowińska, Paweł P Jagodziński

Open access · hybridAbstract read
In one paragraph

Article in Medical science monitor : international medical journal of experimental and clinical research, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Alicja E GrzegorzewskaDepartment of Nephrology, Transplantology and Internal Diseases, Poznań University of Medical Sciences, Poznań, Poland.
Grzegorz OstromeckiDialysis Center, DaVita Clinic Piła, Piła, Poland.
Paulina ZielińskaStudent Nephrology Research Group, Department of Nephrology, Transplantology and Internal Diseases, oznań University of Medical Sciences, Poznań, Poland.
Adrianna MostowskaDepartment of Biochemistry and Molecular Biology, Poznań University of Medical Sciences, Poznań, Poland.
Zofia NiemirDepartment of Nephrology, Transplantology and Internal Diseases, Poznań University of Medical Sciences, Poznań, Poland.
Magdalena Polcyn-AdamczakDepartment of Nephrology, Transplantology and Internal Diseases, Poznań University of Medical Sciences, Poznań, Poland.
Magdalena PawlikDepartment of Nephrology, Transplantology and Internal Diseases, Poznań University of Medical Sciences, Poznań, Poland.
Anna SowińskaDepartment of Computer Science and Statistics, Poznań University of Medical Sciences, Poznań, Poland.
Paweł P JagodzińskiDepartment of Biochemistry and Molecular Biology, Poznań University of Medical Sciences, Poznań, Poland.
Poznan University of Medical Sciences · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND Vitamin D (VD), VD binding protein, VD receptor (VDR), and retinoids are involved in pathogenesis of chronic glomerulonephritis (ChGN). We aimed to compare distribution of VD pathway gene polymorphisms in ChGN patients showing glomerular filtration rate (GFR) category 1-3, GFR category 5D, and healthy controls in order to elucidate the role of VD-related polymorphisms in the course of ChGN. MATERIAL AND METHODS GFR category 1-3 ChGN patients (n=195), GFR category 5D ChGN patients (n=178), and controls (n=751) underwent testing for polymorphisms of genes encoding VD binding protein (GC, rs2298849, rs7041, rs1155563), VDR (VDR, rs2228570, rs1544410), and retinoid X receptor alpha (RXRA, rs10776909, rs10881578, rs749759). RESULTS Among GFR 1-3 subjects possessing TT genotype of RXRA rs10776909, 75% of patients had nephrotic syndrome, and 37.5% had glomerular hyperfiltration defined as GFR >140 ml/min/1.73 m2, and, consequently, serum creatinine was lower in these patients compared to the remaining subjects (0.67±0.26 vs. 0.94±0.34, P=0.014). In GFR category 5D ChGN patients, frequencies of RXRA rs10776909 allele T (25% vs. 19%) and CT+TT (46% vs. 34%) were higher compared to frequencies of respective variants in controls (Ptrend=0.004, Pgenotype=0.008). CONCLUSIONS RXRA rs10776909 allele T is specifically involved in the pathogenesis of ChGN. This risk allele may be also associated with worse clinical course of ChGN.

Indexed as

AdolescentAdultAgedAllelesCase-Control StudiesChronic DiseaseFemaleGene FrequencyGenetic Predisposition to DiseaseGlomerulonephritisHumansMaleMiddle AgedPolymorphism, Single NucleotideReceptors, CalcitriolRenal DialysisReceptors, CalcitriolRetinoid X Receptor alphaVitamin DVitamin D-Binding Protein

Identifiers

PMID26610845
PMCPMC4677740
OpenAlexW2174719397

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.